loading page

Rituximab-Induced Serum Sickness in a Patient with Pemphigus Vulgaris: A Case Report
  • Mohamad Khatib,
  • Solaiman Allafi,
  • Abdulqadir Nashwan
Mohamad Khatib
Hamad Medical Corporation
Author Profile
Solaiman Allafi
Hamad Medical Corporation
Author Profile
Abdulqadir Nashwan
Hamad Medical Corporation
Author Profile

Abstract

Serum sickness, a reaction characterized by fever, rash, myalgia, and arthralgia, can occur in patients who receive chimeric monoclonal antibody therapy. Serum sickness is considered as a rare adverse event following rituximab therapy. We report a case of serum sickness in a newly treated patient with rituximab for pemphigus vulgaris.